ASML Q2: The Business Is Better Than Ever, The Stock Isn't

ASML delivered Q2 strength with €9.3B in sales and €7.59 EPS, both ahead of expectations. Management raised 2026 revenue guidance to €43–45B and lifted gross margin to as high as 56%, supported by improved long-term demand visibility and customer agreements. The update reinforces earnings quality and cyclicality reduction, supporting ASML’s premium valuation.

Analysis

The main takeaway is not just better near-term execution; it is that ASML is moving from a cyclical equipment supplier toward a quasi-annuity on leading-edge wafer starts. That should compress perceived earnings volatility, lower the discount rate investors assign to the stock, and support a higher terminal multiple than a standard semicap name. The immediate winners are ASML shareholders and, secondarily, the advanced-node ecosystem that depends on EUV access; the losers are peers whose growth is still tied to broader fab spend and memory cycles, because ASML’s visibility makes their relative earnings quality look weaker by comparison.

Over the next 1-3 months, the market will likely focus on whether this guidance is being validated by order cadence and customer mix rather than headline revenue alone. The key second-order issue is whether long-term agreements reflect genuine capacity commitment or merely smooth revenue timing; if the latter, the stock could be overbought on the first sign of slower bookings. A harder macro reversal would come from export-control tightening on China or a pause in leading-edge capex from TSMC/Samsung/Intel, which would matter more for sentiment than for 2024 numbers but would directly challenge the 2026 visibility story.

The contrarian view is that the stock may be only partly discounting the structural improvement: if investors still price ASML like a cyclical toolmaker, the rerating can continue. The flip side is that the market may already be paying for perfect execution, so upside depends on margin delivery and not just guidance. Any failure to hold gross margin near the low-50s, or a material miss on order momentum, would quickly falsify the thesis and likely pull the multiple back toward semicap peers.

Key Decisions for Investors

• Add to ASML on any post-print pullback over the next 1-2 weeks; risk/reward favors owning the stock if the market is still treating 2026 visibility as a one-quarter event rather than a structural rerating catalyst.
• Pair trade: long ASML / short a basket of more cycle-sensitive semicap names such as AMAT and LRCX over the next 1-3 months; the long-term agreement mix should support ASML’s earnings quality more than peers still exposed to broader capex volatility.
• Use SOXX or SMH as a hedge if adding ASML aggressively: the stock-specific thesis is stronger than the index, and the ETF can be used to isolate idiosyncratic rerating while reducing beta to a semicap pullback.
• Set a review trigger on the next order-book and gross margin update; if bookings slow materially or gross margin fails to trend toward management’s high-50s target range, trim exposure rather than average down.
• Watch for China export-control headlines and customer capex revisions from TSMC/Samsung/Intel over the next 1-3 months; those are the most plausible falsifiers of the visibility narrative.